Clinical Trials Browser

Phase 2 × Myelodysplastic Syndromes × Hydroxyurea × Clear all

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00083187 2013-07-18

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia

Congenital Abnormalities, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Clinical Trials

Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia